Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 51 min ago
Peer-reviewedCC BYEpidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil

Demographic and clinical factors associated with the distance traveled by people with oral cancer: a cross-sectional study, North and Northeast regions of Brazil, 2017-2023.

  1. 1Universidade Federal da Paraíba Programa de Pós-Graduação em Odontologia João PessoaPB Brazil Universidade Federal da Paraíba, Programa de Pós-Graduação em Odontologia, João Pessoa, PB, Brazil.

Abstract

Objective

To analyze the demographic and clinical factors associated with the distance traveled by people with oral cancer to get hospital treatment in the North and Northeast regions of Brazil, between 2017 and 2023.Methods

This was a cross-sectional study conducted with data from the Hospital Cancer Registry. The dependent variable was defined as the distance, in kilometers, between the municipality of residence and the place of hospital admission, measured by OpenStreetMap. The independent variables included the staging of oral cancer (I, II, III or IV), the region (North or Northeast) and the year of treatment. Gamma regression with logarithmic link function was used to estimate ratios of means (RM) and 95% confidence intervals (95%CI).Results

4,887 records were included. The median distance traveled to treatment was greater in the Northern region (70.9 km). Multivariate analysis revealed significant association between stage IV and greater travel distances (OR 1.05; 95%CI 1.00; 1.11). People from the Northern region (OR 1.38; 95%CI 1.26; 1.51) traveled greater distances to a hospital. A significant increase was observed in 2020 (OR 1.10; 95%CI 1.01; 1.19) and 2022 (OR 1.11; 95%CI 1.02; 1.20).Conclusion

The greatest distances for hospital treatment of oral cancer occurred among people with advanced stages of the disease residing in the Northern region, highlighting inequalities in access to oncological care.

Related

  1. Clinical, neuroimaging, and longitudinal progression characteristics of GBA1-associated Parkinson's disease in a Northeast China cohort.
    Xiaoxiao Du, Xinyu Wang, Pingping Shen +5
    NPJ Parkinson's diseasePeer-reviewedCC BY-NC-NDFull textNeurologyEurope PMCPMCDOAJ
  2. Demographic Representation in Clinical Trials for Transthyretin-Associated Cardiac Amyloidosis: A Systematic Review
    Dimitri Ford, Chima Amadi, Akshay Chandora +6
    Reviews in cardiovascular medicinePeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  3. Latent profiles of physical and psychological symptoms in patients following rectal cancer surgery: Associated demographic and clinical characteristics
    Chen Hu, Yan Chen, Yinjin Li +7
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossref
  4. Comparing Demographic and Clinical Features of Obstructive Sleep Apnea Patients With and Without Sleepiness: A Cross‐Sectional Study
    Fatemeh kashaninasab, Yousef Fathalian, Mahboobeh Khoozan +2
    Brain and BehaviorPeer-reviewedCC BYFull textPhysiologyDOAJ
  5. Treatment Adherence and its Association with Demographic Characteristics and Clinical Factors Among Patients with Hypertension: A Cross-Sectional, Descriptive-Correlational Study.
    Abbas-Ali Vafaei, Raheb Ghorbani, Parnian Zarvani +1
    Vascular health and risk managementPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMCPMC
BibTeX
@article{silva2026demographic,
  title = {{Demographic and clinical factors associated with the distance traveled by people with oral cancer: a cross-sectional study, North and Northeast regions of Brazil, 2017-2023.}},
  author = {Danielle Karla Vieira E Silva and Rênnis Oliveira da Silva and Luciana Leônia Soares Freire and Maria Letícia Barbosa Raymundo and Lilian Nadja Silva Brito and Yuri Wanderley Cavalcanti},
  journal = {Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil},
  year = {2026},
  month = jun,
  doi = {10.1590/s2237-96222026v35e20250749.en},
  url = {https://europepmc.org/article/MED/42922951},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Demographic and clinical factors associated with the distance traveled by people with oral cancer: a cross-sectional study, North and Northeast regions of Brazil, 2017-2023.
AU  - Danielle Karla Vieira E Silva
AU  - Rênnis Oliveira da Silva
AU  - Luciana Leônia Soares Freire
AU  - Maria Letícia Barbosa Raymundo
AU  - Lilian Nadja Silva Brito
AU  - Yuri Wanderley Cavalcanti
PY  - 2026
DA  - 2026/06/19
JO  - Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil
DO  - 10.1590/s2237-96222026v35e20250749.en
UR  - https://europepmc.org/article/MED/42922951
AB  - Objective  To analyze the demographic and clinical factors associated with the distance traveled by people with oral cancer to get hospital treatment in the North and Northeast regions of Brazil, between 2017 and 2023.Methods  This was a cross-sectional study conducted with data from the Hospital Cancer Registry. The dependent variable was defined as the distance, in kilometers, between the municipality of residence and the place of hospital admission, measured by OpenStreetMap. The independent variables included the staging of oral cancer (I, II, III or IV), the region (North or Northeast) and the year of treatment. Gamma regression with logarithmic link function was used to estimate ratios of means (RM) and 95% confidence intervals (95%CI).Results  4,887 records were included. The median distance traveled to treatment was greater in the Northern region (70.9 km). Multivariate analysis revealed significant association between stage IV and greater travel distances (OR 1.05; 95%CI 1.00; 1.11). People from the Northern region (OR 1.38; 95%CI 1.26; 1.51) traveled greater distances to a hospital. A significant increase was observed in 2020 (OR 1.10; 95%CI 1.01; 1.19) and 2022 (OR 1.11; 95%CI 1.02; 1.20).Conclusion  The greatest distances for hospital treatment of oral cancer occurred among people with advanced stages of the disease residing in the Northern region, highlighting inequalities in access to oncological care.
SN  - 1679-4974
SN  - 2237-9622
ER  -